Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure.
Phase of Trial: Phase II
Latest Information Update: 15 Jan 2019
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 30 Jan 2012 Planned number of patients changed from 50 to 150 as reported by ClinicalTrials.gov.
- 20 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.